Penumbra (NYSE: PEN) — Perfil da empresa, notícias e dados financeiros
Penumbra specializes in innovative medical devices for neuro and vascular conditions, aiming to enhance patient outcomes.
Penumbra
Penumbra is a global healthcare company that designs, develops, manufactures, and markets novel medical devices for neurovascular and vascular conditions. Headquartered in Alameda, California, the company specializes in mechanical thrombectomy systems, catheter-based technologies, and embolization coils designed to treat acute ischemic stroke, pulmonary embolism, deep vein thrombosis, peripheral arterial occlusions, and aneurysms. Penumbra serves interventional neuroradiologists, neurosurgeons, interventional cardiologists, and vascular surgeons globally across North America, Europe, Asia, and Latin America. The company's technology platforms integrate aspiration catheters, specialized tubing, and vacuum pump systems to enable minimally invasive surgical procedures.
Resumo
Operações
Produtos e/ou serviços de Penumbra
- Neuro Thrombectomy: Mechanical aspiration catheters and vacuum pumps designed for revascularization and clot removal in patients suffering from acute ischemic stroke caused by intracranial large vessel occlusions in cerebrovascular arteries.
- Peripheral Thrombectomy: Mechanical aspiration systems and specialized catheters engineered to remove blood clots from peripheral blood vessels, treating conditions such as pulmonary embolism, deep vein thrombosis, and acute limb ischemia.
- Neuro Embolization: Detachable platinum occlusion coils and microcatheter delivery systems used by interventional specialists to treat brain aneurysms, arteriovenous malformations, and other cerebral vascular lesions without requiring open brain surgery.
- Peripheral Embolization: Occlusion devices, including platinum microcoils and targeted delivery microcatheters, designed to halt blood flow in specific peripheral vessels to treat acute bleeding, vascular malformations, and arterial lesions.
- Neuro Access Catheters: Microcatheters, guide catheters, and highly trackable delivery devices engineered to provide stable navigational support through complex neurovascular anatomy to facilitate minimally invasive therapeutic procedures.
- Vascular Access and Coronary Thrombectomy: Interventional vascular access sheaths, specialized microcatheters, and mechanical aspiration devices designed to facilitate arterial access and enable targeted thrombus extraction during coronary and peripheral cardiovascular procedures.
equipe executiva do Penumbra
- Adam ElsesserCo-Founder, Chairman & CEO
- Shruthi NarayanPresident
- Arani BoseCo-Founder & Director
- Maggie S. YuenChief Financial Officer
- Lambert ShiuChief Accounting Officer
- Johanna RobertsExecutive VP, General Counsel & Secretary
- Ben SorciExecutive Vice President of Operations
- Jee Hamlyn-HarrisInvestor Relations Officer
- Ben TompkinsExecutive Vice President of Development & Compliance
- Jason Richard MillsExecutive Vice President of Strategy
Principais indicadores financeiros
Resultados divulgados pela Penumbra, em USD.
- Cap. de mercado
- 12,8 bi
- Receita (TTM)
- 1,5 bi
- P/L
- 79.6
- LPA (diluído, TTM)
- 4.1
- Dividend yield
- —
- Margem de lucro
- 10.7%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,4 bi | 189,2 mi | 177,7 mi | |
| 1,2 bi | 86,2 mi | 14 mi | |
| 1,1 bi | 73,6 mi | 91 mi | |
| 847,1 mi | 6,1 mi | -2 mi |